According to Palatin Technologies's latest financial reports the company's total liabilities are โฌ8.75 Million. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-06-30 | โฌ10.11 M | -44.6% |
2023-06-30 | โฌ18.24 M | -3.44% |
2022-06-30 | โฌ18.9 M | 27% |
2021-06-30 | โฌ14.88 M | 242.59% |
2020-06-30 | โฌ4.34 M | 17.94% |
2019-06-30 | โฌ3.68 M | -64.23% |
2018-06-30 | โฌ10.29 M | -81.05% |
2017-06-30 | โฌ54.33 M | 112.14% |
2016-06-30 | โฌ25.61 M | 65.13% |
2015-06-30 | โฌ15.5 M | 666.66% |
2014-06-30 | โฌ2.02 M | 25.62% |
2013-06-30 | โฌ1.61 M | -42.57% |
2012-06-30 | โฌ2.8 M | 36.37% |
2011-06-30 | โฌ2.05 M | -16.24% |
2010-06-30 | โฌ2.45 M | -64.88% |
2009-06-30 | โฌ6.99 M | -12.43% |
2008-06-30 | โฌ7.98 M | -55.75% |
2007-06-30 | โฌ18.04 M | 5.08% |
2006-06-30 | โฌ17.16 M | -21% |
2005-06-30 | โฌ21.73 M | 214.15% |
2004-06-30 | โฌ6.91 M | 94.68% |
2003-06-30 | โฌ3.55 M | -3.96% |
2002-06-30 | โฌ3.69 M | 35.01% |
2001-06-30 | โฌ2.74 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() MediciNova MNOV | โฌ2.16 M | -75.28% | ๐บ๐ธ USA |
![]() GlycoMimetics
GLYC | โฌ2.26 M | -74.13% | ๐บ๐ธ USA |
![]() Neurocrine Biosciences
NBIX | โฌ0.99 B | 11,288.35% | ๐บ๐ธ USA |
![]() ANI Pharmaceuticals ANIP | โฌ0.73 B | 8,292.56% | ๐บ๐ธ USA |
![]() Ligand Pharmaceuticals LGND | โฌ95.15 M | 986.45% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | โฌ100.05 B | 1,142,313.70% | ๐บ๐ธ USA |
![]() Ardelyx ARDX | โฌ0.22 B | 2,514.95% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | โฌ56.38 B | 643,677.93% | ๐ฌ๐ง UK |